34 results
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
an understanding of the fiduciary responsibilities that are required of a member of the board of directors and the commitment of time and energy … acumen, integrity and an ability to exercise sound judgment, as well as a commitment of service to the Company and our board of directors.
The following
8-K
EX-99.1
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
contributions to Black Diamond, and his commitment to exceptional science and to patients in need.“
Dr. Velleca joined the Board of Directors of Black
8-K
EX-10.2
0zc45
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
EX-1.1
tzhxm2jx51qc0mgp
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
s4kv 98nv
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
b8mfb
29 Jun 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.1
jew623rn1 pjvw8l
9 May 23
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:43am
8-K
EX-99.1
9ls44oh7jh54w8x
19 Dec 22
Black Diamond Therapeutics Announces Changes to Board of Directors
8:20am
S-3
vr3lgjnnfqxi
14 Nov 22
Shelf registration
4:15pm
DEF 14A
x914ljsrhx
27 Apr 21
Definitive proxy
4:06pm
S-3ASR
fu26m1yuxhequ9ecn8w
1 Feb 21
Automatic shelf registration
5:28pm
S-3ASR
EX-1.2
xu5rvr
1 Feb 21
Automatic shelf registration
5:28pm
10-K
jpjbd4t
24 Mar 20
Annual report
7:47am